Format

Send to

Choose Destination
Clin Pediatr (Phila). 2011 Dec;50(12):1144-9. doi: 10.1177/0009922811417292. Epub 2011 Oct 18.

Accuracy of neonatal transcutaneous bilirubin measurement in the outpatient setting.

Author information

1
Mayo Clinic, Rochester, MN, USA.

Abstract

OBJECTIVE:

To evaluate the effectiveness of transcutaneous bilirubin (TcB) measurement in predicting risk for neonatal hyperbilirubinemia in outpatients.

DESIGN:

Subjects were infants ≤8 days old seen in an outpatient clinic. Infants discharged with high-risk (HR) or high-intermediate risk (HIR) total serum bilirubin (TSB) values and jaundiced infants were recruited. TSB and TcB (BiliChek) levels were plotted on an hour-specific nomogram to determine risk for hyperbilirubinemia.

RESULTS:

A total of 79 infants provided 87 sets of TcB and TsB values. Mean bias and standard deviation between TcB and TsB was 1.5 ± 2.1 mg/dL for outpatients, compared with 2.7 ± 1.3 mg/dL for inpatients. The sensitivity and specificity of HR or HIR TcB for predicting an HR or HIR TSB were 87% and 58%, respectively. Of 9 infants readmitted for phototherapy, 1 had a low-risk TcB and high-risk TSB.

CONCLUSIONS:

TcB screening in the outpatient environment may not be safe and efficient.

PMID:
22013149
DOI:
10.1177/0009922811417292
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Atypon
Loading ...
Support Center